BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26354773)

  • 1. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
    Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
    J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and genomic features of gliosarcomas.
    Lee D; Kang SY; Suh YL; Jeong JY; Lee JI; Nam DH
    J Neurooncol; 2012 May; 107(3):643-50. PubMed ID: 22270848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary versus secondary gliosarcoma: a systematic review and meta-analysis.
    Vuong HG; Dunn IF
    J Neurooncol; 2022 Aug; 159(1):195-200. PubMed ID: 35768633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
    Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
    Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and survival characteristics of primary and secondary gliosarcoma patients.
    Amer A; Khose S; Alhasan H; Pokhylevych H; Fuller G; Chasen N; de Groot J; Johnson JM
    Clin Neurol Neurosurg; 2022 Mar; 214():107146. PubMed ID: 35101778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliosarcomas with the
    Wang L; Sun J; Li Z; Chen L; Fu Y; Zhao L; Liu L; Wei Y; Teng L; Lu D
    J Clin Pathol; 2017 Dec; 70(12):1079-1083. PubMed ID: 28775171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
    Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
    Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An IDH1-mutated primary gliosarcoma: case report.
    Hsieh JK; Hong CS; Manjila S; Cohen ML; Lo S; Rogers L; Sloan AE
    J Neurosurg; 2017 Feb; 126(2):476-480. PubMed ID: 27153165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic profile of gliosarcomas.
    Reis RM; Könü-Lebleblicioglu D; Lopes JM; Kleihues P; Ohgaki H
    Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
    Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
    J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
    Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
    Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
    Pratt D; Pittaluga S; Palisoc M; Fetsch P; Xi L; Raffeld M; Gilbert MR; Quezado M
    J Neuropathol Exp Neurol; 2017 Aug; 76(8):697-708. PubMed ID: 28789475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.
    Nagaishi M; Kim YH; Mittelbronn M; Giangaspero F; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Legras-Lachuer C; Lachuer J; Ohgaki H
    Am J Pathol; 2012 May; 180(5):1816-23. PubMed ID: 22538188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliosarcoma: Neuroimaging and Immunohistochemical Findings.
    Peckham ME; Osborn AG; Palmer CA; Tsai A; Salzman KL
    J Neuroimaging; 2019 Jan; 29(1):126-132. PubMed ID: 30295979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
    Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
    Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
    Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
    BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.